Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review

BACKGROUND: Pulmonary sarcomatoid carcinoma (PSC) is a rare disease which is highly malignant with a poor prognosis. PSC is highly resistant to chemotherapy and radiotherapy and is prone to recurrence even after surgery. Most of what is known about PSC comes from limited single-center, retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Mei-Na, Ma, Xiao-Ting, Tankere, Pierre, Liam, Chong-Kin, Li, Jin-Li, Wang, Jian-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
iMDT Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577770/
https://www.ncbi.nlm.nih.gov/pubmed/36267791
http://dx.doi.org/10.21037/atm-22-4312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577770/
https://www.ncbi.nlm.nih.gov/pubmed/36267791
http://dx.doi.org/10.21037/atm-22-4312

Ejemplares similares